Albireo Stock Alpha and Beta Analysis

ALBO Stock  USD 44.95  0.40  0.90%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Albireo Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Albireo Pharma over a specified time horizon. Remember, high Albireo Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please continue to Albireo Pharma Backtesting, Albireo Pharma Valuation, Albireo Pharma Correlation, Albireo Pharma Hype Analysis, Albireo Pharma Volatility, Albireo Pharma History and analyze Albireo Pharma Performance.
Please note that although Albireo Pharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Albireo Pharma did 1.52  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Albireo Pharma stock's relative risk over its benchmark. Albireo Pharma has a beta of 1.19  . Let's try to break down what Albireo's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Albireo Pharma will likely underperform.
Albireo Pharma Book Value per Share is quite stable at the moment as compared to the past year. The company's current value of Book Value per Share is estimated at 8.44. Tangible Assets Book Value per Share is expected to rise to 13.69 this year, although Enterprise Value over EBIT will most likely fall to (9.24) .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Enterprise Value

181.22 Million

Albireo Pharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Albireo Pharma market risk premium is the additional return an investor will receive from holding Albireo Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Albireo Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Albireo Pharma's performance over market.
α1.52   β1.19
90 days against NYA

Albireo Pharma expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Albireo Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Albireo Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Albireo Pharma Market Price Analysis

Market price analysis indicators help investors to evaluate how Albireo Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Albireo Pharma shares will generate the highest return on investment. By understating and applying Albireo Pharma stock market price indicators, traders can identify Albireo Pharma position entry and exit signals to maximize returns.

Albireo Pharma Return and Market Media

The median price of Albireo Pharma for the period between Sun, Nov 6, 2022 and Sat, Feb 4, 2023 is 22.11 with a coefficient of variation of 37.21. The daily time series for the period is distributed with a sample standard deviation of 10.4, arithmetic mean of 27.94, and mean deviation of 9.29. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
EPS Reported11/08/2022
Platinum Investment Management Ltd. Has 4.54 Million Holding...11/15/2022
Sale by Weisman Scott of 3851 shares of Albireo Pharma11/30/2022
Chicago Capital LLC Has 21.68 Million Stake in Albireo Pharm...12/21/2022
Ipsen acquiert Albireo, pour acclrer sa croissance dans les ...01/09/2023
Albireo Pharma Elucidating The Ipsen Buyout01/10/2023
Analysts move to downgrade Albireo Pharma after Ipsens propo...01/11/2023
Analysts Set Albireo Pharma, Inc. Price Target at 49.2001/18/2023
International Biotechnology Trust PLC Makes New Investment i...02/01/2023

About Albireo Pharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Albireo or other stocks. Alpha measures the amount that position in Albireo Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 (projected)
PPandE Turnover70.8281.4467.56
Long Term Debt to Equity0.0570.05130.0502

Albireo Pharma Upcoming Company Events

As portrayed in its financial statements, the presentation of Albireo Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Albireo Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Albireo Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Albireo Pharma. Please utilize our Beneish M Score to check the likelihood of Albireo Pharma's management manipulating its earnings.
Upcoming Quarterly Report24th of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Albireo Pharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please continue to Albireo Pharma Backtesting, Albireo Pharma Valuation, Albireo Pharma Correlation, Albireo Pharma Hype Analysis, Albireo Pharma Volatility, Albireo Pharma History and analyze Albireo Pharma Performance. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Albireo Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Albireo Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Albireo Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...